MAPK14 and myeloid sarcoma: In the investigation of MAPK14-related lncRNAs, Ghafouri-Fard et al. discovered that MS patients had upregulated levels of NORAD and RAD51-AS1, suggesting dysregulation in MAPK14-related lncRNAs; however, they did not correlate with the severity of the condition [90, 91].